1. Home
  2. HALO vs URBN Comparison

HALO vs URBN Comparison

Compare HALO & URBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • URBN
  • Stock Information
  • Founded
  • HALO 1998
  • URBN 1970
  • Country
  • HALO United States
  • URBN United States
  • Employees
  • HALO N/A
  • URBN N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • URBN Clothing/Shoe/Accessory Stores
  • Sector
  • HALO Health Care
  • URBN Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • URBN Nasdaq
  • Market Cap
  • HALO 7.4B
  • URBN 6.5B
  • IPO Year
  • HALO N/A
  • URBN 1993
  • Fundamental
  • Price
  • HALO $59.97
  • URBN $75.28
  • Analyst Decision
  • HALO Buy
  • URBN Buy
  • Analyst Count
  • HALO 8
  • URBN 11
  • Target Price
  • HALO $65.63
  • URBN $75.64
  • AVG Volume (30 Days)
  • HALO 1.3M
  • URBN 1.7M
  • Earning Date
  • HALO 08-05-2025
  • URBN 08-20-2025
  • Dividend Yield
  • HALO N/A
  • URBN N/A
  • EPS Growth
  • HALO 55.40
  • URBN 52.13
  • EPS
  • HALO 3.76
  • URBN 4.77
  • Revenue
  • HALO $1,084,306,000.00
  • URBN $5,679,435,000.00
  • Revenue This Year
  • HALO $25.48
  • URBN $10.49
  • Revenue Next Year
  • HALO $19.78
  • URBN $6.69
  • P/E Ratio
  • HALO $15.95
  • URBN $15.77
  • Revenue Growth
  • HALO 25.64
  • URBN 8.38
  • 52 Week Low
  • HALO $42.01
  • URBN $33.86
  • 52 Week High
  • HALO $70.51
  • URBN $78.22
  • Technical
  • Relative Strength Index (RSI)
  • HALO 64.61
  • URBN 56.19
  • Support Level
  • HALO $57.68
  • URBN $73.09
  • Resistance Level
  • HALO $59.38
  • URBN $78.12
  • Average True Range (ATR)
  • HALO 1.32
  • URBN 2.38
  • MACD
  • HALO 0.26
  • URBN 0.11
  • Stochastic Oscillator
  • HALO 70.87
  • URBN 69.21

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About URBN Urban Outfitters Inc.

Founded in 1970, Philadelphia-based Urban Outfitters is an apparel and home goods retailer that operates more than 700 stores and e-commerce in the United States, which accounts for about 87% of sales, and other regions. Its retail nameplates are Urban Outfitters (23% of fiscal 2025 sales), Free People/Movement (26%), and Anthropologie (44%). Retail accounted for 88% of fiscal 2025 revenue, but Urban Outfitters also sells products through a wholesale operation, owns some restaurants, and operates a fast-growing clothing rental and resale business called Nuuly (7% of sales). Urban Outfitters primarily markets to young adults and offers products in categories such as apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.

Share on Social Networks: